About Single Cell Technology
Single Cell Technology is a company based in San Jose (United States) founded in 2008.. Single Cell Technology has raised $2.46 million across 3 funding rounds. The company has 9 employees as of December 31, 2022. Single Cell Technology offers products and services including AbTheneum Platform. Single Cell Technology operates in a competitive market with competitors including Omniome, Adimab, Novogene Corporation, HitGen and Singular Genomics, among others.
- Headquarter San Jose, United States
- Employees 9 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$00as on Feb 18, 2021
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.46 M (USD)
in 3 rounds
-
Latest Funding Round
$2.14 M (USD), Seed
Jan 22, 2021
-
Investors
-
Employee Count
9
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Single Cell Technology
Single Cell Technology offers a comprehensive portfolio of products and services, including AbTheneum Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform that captures data for efficient antibody discovery processes.
Unlock access to complete
Unlock access to complete
Funding Insights of Single Cell Technology
Single Cell Technology has successfully raised a total of $2.46M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.14 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $2.1M
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Seed - Single Cell Technology | Valuation |
investors |
|
| Dec, 2012 | Amount | Debt – Conventional - Single Cell Technology | Valuation |
investors |
|
| Dec, 2012 | Amount | Seed - Single Cell Technology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Single Cell Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Single Cell Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Single Cell Technology Comparisons
Competitors of Single Cell Technology
Single Cell Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Adimab, Novogene Corporation, HitGen and Singular Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Antibodies are discovered and optimized for autoimmune and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Next-generation gene sequencing and multi-omics technologies are provided.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Single Cell Technology
When was Single Cell Technology founded?
Single Cell Technology was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Where is Single Cell Technology located?
Single Cell Technology is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is Single Cell Technology a funded company?
Single Cell Technology is a funded company, having raised a total of $2.46M across 3 funding rounds to date.
How many employees does Single Cell Technology have?
As of Dec 31, 2022, the latest employee count at Single Cell Technology is 9.
What does Single Cell Technology do?
Single Cell Technology develops and licenses a technology platform that discovers and analyzes antibodies and mRNA from individual antibody-secreting cells. Its platform examines and screens plasma cells in lymphoid tissues against various molecules in various hosts, including humans, mouse cells, and other organisms for measuring their affinity and specificity from cognate light and heavy chains. It also provide the DNA sequences of the antibody cognate light and heavy chains, and structural inference for each antibody. It is involved in contract services for the antibody repertoire of the immune response to pharmaceutical and biopharmaceutical companies.
Who are the top competitors of Single Cell Technology?
Single Cell Technology's top competitors include Adimab, Novogene Corporation and BGI.
What products or services does Single Cell Technology offer?
Single Cell Technology offers AbTheneum Platform.